Abiopharma

News list

📋 MITCHELL CHAN (Director) plans to sell 3K shares of AVALO THERAPEUTICS, INC. (at $16.26 each, total $51K) Filed: May 06, 2026 | ID: 004138

Full text

News bot May 6, 2026, 8:30 p.m.
📋 Form 144 Filing: MITCHELL CHAN

Company: AVALO THERAPEUTICS, INC.

Filing Date: 2026-05-06

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 3,167
- Price per Share: $16.26
- Total Value: $51,495.42
- Planned Sale Date: 2026-05-06
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-37590
- Issuer Contact Phone: 4105228707
- Issuer Address: 1500 Liberty Ridge Drive, Suite 321, Wayne, PA, 19087
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 22788452.0
- Number of Securities to be Sold: 1
- Signature: /s/ Mitchell Chan
- Plan Adoption Dates: 2025-11-19